Douglas Lane & Associates, LLC

Position in GRAL — GRAIL, Inc.

CIK 1672594 NEW YORK, NY

Position in GRAL

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$11,082,951

+$2,735,391 QoQ

Shares Held

162,340

+0.5% QoQ

Ownership

0.378%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

of 29 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Douglas Lane & Associates, LLC holds $266,821,801 across 4 Diagnostics & Research names. GRAL ranks #4 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	221,679	$111,140,983
2	DHR	Danaher Corp /De/	459,416	$87,509,559
3	ILMN	Illumina, Inc.	324,679	$57,088,308
4	GRAL	GRAIL, Inc. This page	162,340	$11,082,951

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,082,951	162,340	+0.5%	Shares	Sole	2026-07-14
2026-03-31	$8,347,560	161,524	-0.1%	Shares	Sole	2026-04-15
2025-12-31	$13,833,398	161,624	-4.0%	Shares	Sole	2026-01-22
2025-09-30	$9,952,525	168,316	-0.2%	Shares	Sole	2025-10-10
2025-06-30	$8,671,777	168,646	-0.8%	Shares	Sole	2025-07-07
2025-03-31	$4,341,340	169,982	+0.0%	Shares	Sole	2025-04-09
2024-12-31	$3,034,089	169,977	+40.6%	Shares	Sole	2025-01-08
2024-09-30	$1,663,831	120,918	+192.9%	Shares	Sole	2024-10-10
2024-06-30	$634,581	41,287	—	Shares	Sole	2024-07-08
No filing history on record for this holder in this stock.